These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19755910)

  • 21. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved quality of life with effective treatment of facial melasma: the pigment trial.
    Balkrishnan R; Kelly AP; McMichael A; Torok H
    J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
    Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
    Torok HM
    Am J Clin Dermatol; 2006; 7(4):223-30. PubMed ID: 16901182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Draelos Z
    Dermatol Surg; 2011 Jan; 37(1):126-7. PubMed ID: 21214668
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative Efficacy Of 35% Glycolic Acid Peel vs. Jessner Peel as an Adjuvant to Topical Triple Combination (2% Hydroquinone, 0.025% Tretinoin, 0.01% Fluocinolone Acetonide) Therapy in Melasma Females Cases.
    Modi A; Parmar S; Marfatiya Y
    J Cosmet Sci; 2021; 72(4):418-431. PubMed ID: 35262482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study.
    Passeron T; Fontas E; Kang HY; Bahadoran P; Lacour JP; Ortonne JP
    Arch Dermatol; 2011 Sep; 147(9):1106-8. PubMed ID: 21931054
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
    Figueiredo Souza L; Trancoso Souza S
    Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
    Moncada B; Castillo-Martínez C; Arenas E; León-Bejarano F; Ramírez-Elías MG; González FJ
    Skin Res Technol; 2016 May; 22(2):170-3. PubMed ID: 26179661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
    Hexsel D; Soirefmann M; Fernandes JD; Siega C
    J Drugs Dermatol; 2014 Apr; 13(4):444-8. PubMed ID: 24719064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
    Astaneh R; Farboud E; Nazemi MJ
    Int J Dermatol; 2005 Jul; 44(7):599-601. PubMed ID: 15985034
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
    Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Facial melanosis (melasma)].
    Witkiewicz IM; Neering H
    Ned Tijdschr Geneeskd; 1981 Apr; 125(16):609-11. PubMed ID: 7242709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for melasma.
    Rajaratnam R; Halpern J; Salim A; Emmett C
    Cochrane Database Syst Rev; 2010 Jul; (7):CD003583. PubMed ID: 20614435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.